Hancox, J. C., Melgari, D., Dempsey, C. E., Brack, K. E., Mitcheson, J., & Ng, G. A. (2015). hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes. Ther Adv Drug Saf.

Hancox, Jules C., Dario Melgari, Christopher E. Dempsey, Kieran E. Brack, John Mitcheson, و G. André Ng. "HERG Potassium Channel Inhibition By Ivabradine May Contribute to QT Prolongation and Risk of Torsades De Pointes." Ther Adv Drug Saf 2015.

Hancox, Jules C., et al. "HERG Potassium Channel Inhibition By Ivabradine May Contribute to QT Prolongation and Risk of Torsades De Pointes." Ther Adv Drug Saf 2015.